Table 1

Demographic and clinical characteristics of the study sample at three time points

Baseline assessment (n = 167)

3 months follow-up (n = 150)

18 months follow-up (n = 99)

P*


No (%)

No (%)

No (%)


Age groups (years)

0.03

24–34

33 (19.8)

29 (19.3)

18 (18.2)

35–44

46 (27.5)

40 (26.7)

29 (29.3)

45–54

39 (23.4)

38 (25.3)

30 (30.2)

55–64

28 (16.8)

26 (17.3)

15 (15.2)

64 >

21 (12.5)

17 (11.4)

7 (7.1)

Mean (SD)

47.2 (13.5)

47.4 (13.3)

46.4 (12.5)

Range

24–81

24–81

24–81

Educational level

0.05

Illiterate

38 (22.8)

34 (22.7)

17 (17.2)

Primary

78 (46.7)

71 (47.3)

45 (45.5)

Secondary

33 (19.8)

29 (19.3)

25 (25.2)

College/university

18 (10.7)

16 (10.7)

12 (12.1)

Marital status

0.4

Single

15 (9.0)

13 (8.7)

11 (11.1)

Married

116 (69.4)

105 (70.0)

67 (67.7)

Widowed

36 (21.6)

32 (21.3)

21 (21.2)

Disease stage

0.4

Local

29 (17.4)

25 (16.7)

18 (18.2)

Loco-regional

76 (45.5)

71 (47.3)

48 (48.5)

Metastasis

62 (37.1)

54 (36.0)

33 (33.3)

Initial management

0.09

Mastectomy

138 (82.6)

125 (83.3)

84 (84.8)

Conservative surgery

15 (9.0)

14 (9.3)

11 (11.1)

Chemotherapy

11 (6.6)

10 (6.7)

4 (4.1)

Best supportive care

3 (1.8)

1 (0.7)

0 (0.0)


2 test

Montazeri et al. BMC Cancer 2008 8:330   doi:10.1186/1471-2407-8-330

Open Data